PC
AMRI

Paulson & Co’s Albany Molecular Research Inc AMRI Stock Holding History

Paulson & Co’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-314,200
Closed -$6.82M – 110
2017
Q2 		$6.82M Buy
+314,200
New +$5.7M 0.09% 76

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Paulson & Co's AMRI Position: Q3 2017 in Review

Paulson & Co sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 314,200 shares — an estimated $6.82M sold.

Paulson & Co first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $6.82M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Paulson & Co reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Paulson & Co sold 314,200 Albany Molecular Research Inc shares in Q3 2017, an estimated $6.82M.
  • Paulson & Co first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Paulson & Co's Albany Molecular Research Inc position peaked at $6.82M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.